References
- 1. Marashi SM, Nasri-Nasrabadi Z. Can sodium bicarbonate really help in treating metabolic acidosis caused by aluminium phosphide poisoning? Arh Hig Rada Toksikol 2015;66:83-4. doi: 10.1515/aiht-2015-66-2637
- 2. Siwach SB, Jagdish K, Katyal VK, Dhall A, Bhardwaj G. Prognostic indices in aluminium phosphide poisoning: Observations on acidosis and central venous pressure. J Assoc Physicians India 1997;45:693-5.
- 3. Siddaiah LM, Adhyapak SM, Jaydev SM, Shetty GG, Varghese K, Patil CB, Iyengar SS. Intra-aortic balloon pump in toxic myocarditis due to aluminum phosphide poisoning. J Med Toxicol 2009;5:80-3. doi: 10.1007/BF03161093
- 4. Agrawal VK, Bansal A, Singh RK, Kumawat BL, Mahajan P. Aluminium phopsphide poisoning: possible role of supportive measures in the absence of specific antidote. Indian J Crit Care Med 2015;19:109-12. doi: 10.4103/0972-5229.151019
- 5. Chefurka W, Kashi KP, Bond EJ. The effect of phosphine on electron transport in mitochondria. Pestic Biochem Physiol 1976;6:65-84. doi:10.1016/0048-3575(76)90010-9
- 6. Jaiswal S, Verma RK, Tewari N. Aluminum phosphide poisoning: Effect of correction of severe metabolic acidosis on patient outcome. Indian J Crit Care Med 2009;13:21-4. doi: 10.4103/0972-5229.53111
- 7. Soltaninejad K, Nelson LS, Bahreini SA, Shadnia S. Fatal aluminum phosphide poisoning in Tehran-Iran from 2007 to 2010. Indian J Med Sci 2012;66:66-70. doi: 10.4103/0019-5359.110909
- 8. Shadnia S, Mehrpour O, Soltaninejad K. A simplified acute physiology score in the prediction of acute aluminum phosphide poisoning outcome. Indian J Med Sci 2010;64:532-9. doi: 10.4103/0019-5359.75928
- 9. Jain AK, Nigam M, Garg SD, Dubey BP, Arora A. Aluminium phosphide poisoning autopsy findings. J Indian Acad Forensic Med (JIAFM) 2005;27:35-9.
- 10. Mehrpour O, Dolati M, Soltaninejad K, Shadnia S, Nazparvar B. Evaluation of histopathological changes in fatal aluminum phosphid e poisoning. Indian J Forensic Med Toxicol 2008;2:34-6 [displayed 4 March 2015]. Available from: http://www.indmedica.com/journals.php?journalid=11&issueid=131&articleid=1739&action=article
- 11. Marashi SM, Arefi M, Behnoush B, Nasrabad MG, Nasri Nasrabadi Z. Could hydroxyethyl starch be a therapeutic option in management of acute aluminum phosphide toxicity? Med Hypotheses 2011;76:596-8. doi: 10.1016/j. mehy.2011.01.009
- 12. Marashi SM, Majidi M, Raji Asadabadi H, Nasri Nasrabadi Z. A common misconception in the management of aluminium phosphide poisoning. Arh Hig Rada Toksikol 2013;64:475-6. doi: 10.2478/10004-1254-64-2013-2404
- 13. Nasri Nasrabadi Z, Marashi SM. Comments on “A systematic review of aluminium phosphide poisoning”. Arh Hig Rada Toksikol 2012;63:551. doi: 10.2478/10004-1254-63-2012-2321
- 14. Marashi SM, Majidi M, Sadeghian M, Ahmadi S, Raji Asadabadi H, Nasri Nasrabadi Z. Is the use of cardioactive steroids appropriate in managing aluminium phosphide poisoning-induced heart failure? Arh Hig Rada Toksikol 2013;64:477-8. doi: 10.2478/10004-1254-64-2013-2439
- 15. Hartog CS, Natanson C, Sun J, Klein HG, Reinhart K. Concerns over use of hydroxyethyl starch solutions. BMJ 2014;349:g5981. doi: 10.1136/bmj.g5981
- 16. Jonville-Bera AP, Autret-Leca E, Gruel Y. Acquired type I von Willebrand’s disease associated with highly substituted hydroxyethyl starch. N Engl J Med 2001;345:622-3. doi: 10.1056/NEJM200108233450818
- 17. Rioux JP, Lessard M, De Bortoli B, Roy P, Albert M, Verdant C, Madore F, Troyanov S. Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med 2009;37:1293-8. doi: 10.1097/CCM.0b013e31819cc1a0
- 18. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA; CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367:1901-11. doi: 10.1056/NEJMoa1209759
- 19. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J; 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 2012;367:124-34. doi: 10.1056/NEJMoa1204242
- 20. Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J, Forceville X, Feissel M, Hasselmann M, Heininger A, Van Aken H. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012;16:R94. doi: 10.1186/ cc11358